Keynote Speaker



Robert Fraser, PhD
President and Chief Executive Officer, Molecular You

Abstract:

There is a revolution in healthcare in which health decisions will be preventive, data-driven and personalized. Biomarker analysis gives us health insights like never before and allows us to take proactive measures to manage health.

Visual analytics will play a key role in turning the vast amounts of health information into understandable, actionable insights. Molecular You is a digital health company developing an AI-driven playbook for personalized health to guide individuals to reach optimal health. The company has employed several visual analytic tools in its digital health platform to make the dynamic health information easy to understand for consumers and health practitioners.





Bio:
Robert Fraser, PhD
President and Chief Executive Officer, Molecular You
www.molecularyou.com

Dr. Rob Fraser is the co-founder and President and CEO of Molecular You, a digital health company utilizing integrated biomarker analyses to deliver personalized health insights and action plans. For the past decade, Dr. Fraser has spent his career advancing digital health technologies to bring personalized healthcare into practice. Backed by his expertise in molecular diagnostics, molecularly-targeted drug discovery and development, biochemistry and regulatory compliance, he formed Molecular You to address the need to integrate diverse data sets into one simple-to-use digital health platform accessible across the scientific, medical and layperson spectrum. The company’s health assessments analyze the most diverse range of biomarkers in North America to give insights into inherited risks, current state of health and early warning signs. A personalized lifestyle action plan is then designed to stay healthy and slow or reverse the progression of disease. The company is comprised of leading experts in life sciences, bioinformatics, block-chain, AI, design, data visualization and medical practice. Dr. Fraser is also the co-founder of the Personalized Medicine Initiative, GenXys Health Care Systems and Personalized Biomarkers Incorporated.